Related Experiment Videos

Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse

Zinal S Chheda1, Sabine Mueller2,3,4,5, Bindu Hegde6

  • 1Sanofi Genzyme, Cambridge, Massachusetts, USA.

Journal for Immunotherapy of Cancer
|March 21, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Antigens, NeoplasmBrain NeoplasmsCD8-Positive T-LymphocytesImmunotherapyT-Lymphocytes

Related Concept Videos